| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/17/2023 | Travere Therapeutics, Inc. | RTRX | Grant | | 4.5k | $0.00 | $0 | | 05/17/2023 |
| 05/17/2023 | Travere Therapeutics, Inc. | RTRX | Grant | | 13.5k | $17.11 | $231k | | 05/17/2023 |
| 05/11/2022 | Travere Therapeutics, Inc. | RTRX | Grant | | 9k | $21.38 | $192.4k | | 05/11/2022 |
| 05/11/2022 | Travere Therapeutics, Inc. | RTRX | Grant | | 3k | $0.00 | $0 | | 05/11/2022 |
| 05/14/2021 | Travere Therapeutics, Inc. | RTRX | Grant | | 9k | $18.27 | $164.4k | | 05/14/2021 |
| 05/14/2021 | Travere Therapeutics, Inc. | RTRX | Grant | | 3k | $0.00 | $0 | | 05/14/2021 |
| 05/15/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 3k | $0.00 | $0 | | 05/15/2020 |
| 05/15/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 9k | $15.43 | $138.9k | | 05/15/2020 |
| 05/13/2019 | Travere Therapeutics, Inc. | RTRX | Grant | Stock Option (Right to Buy) | 14k | $17.87 | $250.2k | | 05/13/2019 |
| 05/13/2019 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 3.5k | $0.00 | $0 | | 05/13/2019 |
| 10/18/2018 | LogicBio Therapeutics, Inc. | LOGC | Grant | Employee Stock Option (right to buy) | 106.3k | $10.00 | $1.1M | | 10/18/2018 |
| 10/18/2018 | LogicBio Therapeutics, Inc. | LOGC | Grant | Employee Stock Option (right to buy) | 77.5k | $10.00 | $775k | | 10/18/2018 |